Literature DB >> 3146883

Persistent obesity and short final height after corticoid overtreatment for congenital adrenal hyperplasia (CAH) in infancy.

D Knorr, S G Hinrichsen de Lienau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3146883

Source DB:  PubMed          Journal:  Acta Paediatr Jpn        ISSN： 0374-5600


× No keyword cloud information.
  5 in total

Review 1.  Growth in congenital adrenal hyperplasia.

Authors:  An Tt Nguyen; Justin J Brown; Garry L Warne
Journal:  Indian J Pediatr       Date:  2006-01       Impact factor: 1.967

2.  Outcome of congenital adrenal hyperplasia.

Authors:  U Kuhnle; M Bullinger
Journal:  Pediatr Surg Int       Date:  1997-09       Impact factor: 1.827

3.  Longitudinal analysis of growth and puberty in 21-hydroxylase deficiency patients.

Authors:  H J Van der Kamp; B J Otten; N Buitenweg; S M P F De Muinck Keizer-Schrama; W Oostdijk; M Jansen; H A Delemarre-de Waal; T Vulsma; J M Wit
Journal:  Arch Dis Child       Date:  2002-08       Impact factor: 3.791

4.  Obesity in 21-hydroxylase deficient patients.

Authors:  R E Cornean; P C Hindmarsh; C G Brook
Journal:  Arch Dis Child       Date:  1998-03       Impact factor: 3.791

5.  Blood Pressure and Left Ventricular Characteristics in Young Patients with Classical Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency.

Authors:  Graziamaria Ubertini; Carla Bizzarri; Armando Grossi; Fabrizio Gimigliano; Lucilla Ravà; Danilo Fintini; Marco Cappa
Journal:  Int J Pediatr Endocrinol       Date:  2010-02-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.